NEW AMSTERDAM PARTNERS LLC/NY - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 280 filers reported holding MYRIAD GENETICS INC in Q3 2014. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.

Quarter-by-quarter ownership
NEW AMSTERDAM PARTNERS LLC/NY ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2014$4,115,000
-88.2%
106,698
-88.1%
0.28%
-87.9%
Q2 2014$34,887,000
+13.8%
896,379
-0.0%
2.27%
+8.2%
Q1 2014$30,657,000
+43.7%
896,677
-11.8%
2.10%
+48.6%
Q4 2013$21,327,000
-53.7%
1,016,524
-48.1%
1.41%
-8.1%
Q3 2013$46,022,000
+110.8%
1,958,356
+141.0%
1.54%
+32.0%
Q2 2013$21,836,000812,6561.16%
Other shareholders
MYRIAD GENETICS INC shareholders Q3 2014
NameSharesValueWeighting ↓
Consonance Capital Management LP 3,309,206$109,866,0006.94%
SG Capital Management LLC 604,159$20,058,0003.66%
KESTREL INVESTMENT MANAGEMENT CORP 232,975$7,735,0003.57%
Broadfin Capital, LLC 500,000$16,600,0003.43%
Tieton Capital Management, LLC 98,199$3,260,0002.90%
SG Capital Management LLC 350,000$11,620,0002.12%
DISCIPLINED GROWTH INVESTORS INC /MN 2,852,064$94,689,0001.66%
Broadfin Capital, LLC 240,000$7,968,0001.64%
Millrace Asset Group, Inc. 58,302$1,936,0001.63%
PURA VIDA INVESTMENTS, LLC 300,000$9,960,0001.42%
View complete list of MYRIAD GENETICS INC shareholders